Director, Medical Science Liaison, Oncology Texas (Houston, Austin, San Antonio)

Darum lohnt es sich

As a new member of the Revolution Medicines team, you will join other outstanding professionals in a tireless commitment to patients with cancers harboring mutations in the RAS signaling pathway. Opportunity We are seeking a highly motivated and experienced professional to join our team as a Lung Medical Science Liaison.

Key aspects of this role will include engaging in peer‑to‑peer scientific dialogue with healthcare professionals that translate into meaningful insights, serving as a therapeutic expert and thought partner to internal teams, acting as a liaison between Revolution Medicines and clinical study sites/investigators, and providing support for medical education, advisory boards, and medical congresses.

Responsibilities • Develop and maintain strong relationships with KOLs, healthcare professionals, and academic institutions to advance scientific and medical knowledge. • Communicate clinical and scientific data to KOLs and healthcare professionals through presentations, educational programs, and scientific discussions. • Support the synthesis and communication of scientific insights from KOLs to relevant internal teams. • Provide scientific support for medical congresses, advisory boards and other relevant scientific engagements to enhance the visibility of RevMed within the scientific and medical communities. • Establish credibility as a scientific expert and resource for internal stakeholders, providing medical and scientific support for products and therapeutic areas. • Collaborate cross‑functionally with medical affairs, clinical development, marketing and other teams to support the development and execution of medical strategies and tactics. • Stay current with scientific literature, emerging research, and competitive landscape. • Adhere to Revolution Medicines Core Values and policies. • Understand the regulatory requirements for customer engagement by field‑based employees.

Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS‑addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins.

The company’s RAS(ON) inhibitors daraxonrasib (RMC-6236), a RAS(ON) multi‑selective inhibitor; elironrasib (RMC-6291), a RAS(ON) G12C‑selective inhibitor; zoldonrasib (RMC-9805), a RAS(ON) G12D‑selective inhibitor; and RMC-5127, a RAS(ON) G12V‑selective inhibitor, are currently in clinical development.

Required Skills, Experience and Education • Doctoral degree in a scientific or medical discipline. • 8+ years experience as an MSL or in a similar role within the pharmaceutical or biotech industry. • 3+ years experience as an MSL working in the lung cancer disease state area. • Strong understanding of clinical research methodologies and drug development processes. • Knowledge and experience within the oncology therapeutic area. • Excellent verbal and written communication skills. • Proven ability to analyze and synthesize scientific information effectively. • Excellent presentation skills, with the ability to effectively communicate complex scientific data to diverse audiences. • Strong networking skills with proven ability to successfully build and maintain relationships with KOLs and healthcare professionals. • Self‑directed and able to thrive in a fast‑paced and dynamic environment. • Willingness to travel up to 60% of time.

Preferred Skills • Preferred experience in lung and gastrointestinal cancers. • Experience with both early and late stage clinical assets as well as approved therapies.

Base Pay Salary Range $236,000—$259,000 USD Revolution Medicines is an equal opportunity employer and prohibits unlawful discrimination based on race, color, religion, gender, sexual orientation, gender identity/expression, national origin/ancestry, age, disability, marital status, medical condition, and veteran status.